A detailed history of Winthrop Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Winthrop Capital Management, LLC holds 1,965 shares of ABT stock, worth $228,726. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,965
Holding current value
$228,726
% of portfolio
0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$100.73 - $112.44 $197,934 - $220,944
1,965 New
1,965 $204,000
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $189,849 - $232,392
2,105 New
2,105 $232 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $204B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Winthrop Capital Management, LLC Portfolio

Follow Winthrop Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winthrop Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winthrop Capital Management, LLC with notifications on news.